The contribution of candidate genes to the response of plasma lipids and lipoproteins to dietary challenge

Atherosclerosis

Volumn 152, Issue 1, 2000, Pages 239-248

  Friedlander, Yechiel ^a   Leitersdorf, Eran ^b   Vecsler, Roni ^a   Funke, Harald ^c   Kark, Jeremy ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Diet; Genetics; Lipids; Lipoproteins

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIGNAL PEPTIDE; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CHOLESTEROL BLOOD LEVEL; DIETARY INTAKE; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GENE MUTATION; GENOTYPE; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADOLESCENT; ADULT; AGED; BASE SEQUENCE; CARRIER PROTEINS; CHOLESTEROL, DIETARY; COMPARATIVE STUDY; CROSS-OVER STUDIES; DIET; DIETARY FATS; FEMALE; HUMAN; LIPOPROTEIN LIPASE; MALE; MIDDLE AGE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; POLYMORPHISM (GENETICS); SENSITIVITY AND SPECIFICITY; SUPPORT, NON-U.S. GOV'T;

EID: 0034283526     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00474-8     Document Type: Article

References (73)

1. Katan M., Beynen A.C., DeVries J.H., Nobles A.A. Existence of consistent hypo- and hyperresponders to dietary cholesterol in man. Am. J. Epidemiol. 123:1986;221-234.
2. Katan M.B., Berns M.A., Glatz J.F., Knuiman J.T., Nobels A., de Vries J.H. Congruence of individual responsiveness to dietary cholesterol and to saturated fat in humans. J. Lipid Res. 29:1988;883-892.
3. Katan M.B., van Gastel A.C., de Rover C.M., van Montfort M.A.J., Knuiman J.T. Differences in individual responsiveness of serum cholesterol to fat-modified diets in man. Eur. J. Clin. Invest. 18:1988;644-647.
4. Beynen A.C., Katan M.B., van Zutphen L.F. Hypo- and hyperresponders: individual differences in the response of serum cholesterol concentration to changes in diet. Adv. Lipid Res. 22:1987;115-171.
5. Beynen A.C., Katan M.B. Hypo- and hyperresponders to dietary cholesterol. Am. J. Clin. Nutr. 43:1986;974-987.
6. Mensink R.P., Katan M.B. Effect of monounsaturated fatty acids versus complex carbohydrates on high density lipoprotein in healthy men and women. Lancet. 1:1987;122-125.
7. Cobb M.M., Risch N. Low-density lipoprotein cholesterol responsiveness to diet in normolipidemic subjects. Metabolism. 42:1993;7-13.
8. Clifton P.M., Abbey M., Noakes M., Beltame S., Rumbelow N., Nestel P.J. Body fat distribution is a determinant of the high-density lipoprotein response to dietary fat and cholesterol in women. Arterioscler. Thromb. Vasc. Biol. 15:1995;1070-1078.
9. Cobb M.M., Teitlebaum H. Determinants of plasma cholesterol responsiveness to diet. Br. J. Nutr. 71:1994;271-284.
10. Law A., Powell L.M., Brunt H., Knott T.J., Altman D.G., Rajput J., Wallis S.C., Pease R.J., Priestley L.M., Scott J., Miller G.J., Miller N.E. Common DNA polymorphism within coding sequence of apolipoprotein B gene associated with altered lipid levels. Lancet. 1:1986;1301-1303.
11. Talmud P.J., Barni N., Kessling A.M., Carlsson P., Darnfors C., Bjursell G., Galton D.J., Wynn V., Humphries S.E. Apolipoprotein B gene variants are involved in the determination of serum cholesterol levels: a study in normo- and hyperlipidaemic individuals. Atherosclerosis. 67:1987;81-89.
12. Xu C.-F., Tikkanen M.J., Huttunen J.K., Pietinen P., Butler R., Humphries S., Talmud P. Apolipoprotein B signal peptide insertion/deletion polymorphism is associated with Ag epitopes and involved in the determination of serum triglyceride levels. J. Lipid Res. 31:1990;1255-1261.
13. Boerwinkle E., Chen S.-H., Visvikis S., Hanis C.L., Siest G., Chan L. Signal peptide-length variation in human apolipoprotein B gene; molecular characteristics and association with plasma glucose levels. Diabetes. 40:1991;1539-1544.
14. Friedlander Y., Kaufmann N.A., Cedar H., Weinberg N., Kark J.D. The role of XbaI polymorphism of the apolipoprotein B gene in determining levels and covariability of lipids and lipoprotein variables in a sample of Israeli offspring with family history of myocardial infarction. Atherosclerosis. 98:1993;165-177.
15. Hegele R.A., Huang L.S., Herbert P.N., Blum C.B., Buring J.E., Hennekens C.H., Breslow J.L. Apolipoprotein B gene DNA polymorphisms associated with myocardial infarction. N. Engl. J. Med. 315:1986;1509-1515.
16. Deeb S., Failor A., Brown B.G., Brunzell J.D., Albers J.J., Motulsky A.G. Molecular genetics of apolipoproteins and coronary heart disease. Cold Spring Harbor Symp. Quant. Biol. 51:1986;403-409.
17. Sing C.F., Davignon J. Role of apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am. J. Hum. Genet. 37:1985;268-285.
18. Jemaa R., Tuzet S., Portos C., Betoulle D., Apfelbaum M., Fumeron F. Lipoprotein lipase gene polymorphism: association with hypertriglyceridemia and body mass index in obese people. Int. J. Obesity. 19:1995;270-274.
19. Chen L., Pastch W., Boerwinkle E. HindIII DNA polymorphism in the lipoprotein lipase gene and plasma lipid phenotypes and carotid artery atherosclerosis. Hum. Genet. 98:1996;551-566.
20. Kondo I., Berg K., Drayana D., Lawn R. DNA polymorphism at the locus for cholesteryl ester transfer protein (CETP) is associated with high density lipoprotein cholesterol and apolipoprotein levels. Clin. Genet. 35:1989;49-56.
21. Freeman D.J., Packard C.J., Gaffney D. Polymorphisms in the gene coding for cholesteryl ester transfer protein are related to plasma high-density cholesterol and transfer protein activity. Clin. Sci. 79:1990;575-581.
22. Fumeron F., Betoulle D., Luc G., Behague I., Ricard S., Poirier O., Jemaa R., Evans A., Arveiler D., Marques-Vidal P., et al. Alcohol intake modulates the effect of polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J. Clin. Invest. 96:1995;1664-1671.
23. Berg K. Variability gene effect on cholesterol at the Kidd blood group locus. Clin. Genet. 33:1988;102-107.
24. Berg K., Kondo I., Drayna D., Lawn R. 'Variability gene' effect of cholesterol ester transfer protein (CETP) genes. Clin. Genet. 35:1989;437-445.
25. Monsalve M.V., Roninson D., Woolcock N.E., Powell J.T., Greenhalgh R.M., Humphries S.E. Within-individual variation in serum cholesterol levels: association with DNA polymorphisms at the apolipoprotein B and AI-CIII-AIV loci in patients with peripheral arterial disease. Clin. Genet. 39:1991;260-273.
26. Friedlander Y., Austin M.A., Newman B., Edwards K., Mayer-Davis E.L., King M.C. Heritability of longitudinal changes in coronary heart disease risk factors in women twins. Am. J. Hum. Genet. 60:1996;1502-1512.
27. Tikkanen M.J., Xu C.-F., Hamalainen T., Talmud P., Sarna S., Huttunen J.K., Pietinen P., Humphries S.E. XbaI polymorphism of the apolipoprotein B gene influences plasma lipid response to diet intervention. Clin. Genet. 37:1990;327-334.
28. Xu C.-F., Boerwinkle E., Tikkanen M.J., Humphries S.E., Talmud P.J. Genetic variation at the apolipoprotein gene loci contribute to response of plasma lipids to dietary change. Genet. Epidemiol. 7:1990;261-275.
29. Abbey M., Belling B., Clifton P., Nestel P. Apolipoprotein B gene polymorphism associates with plasma cholesterol changes induced by dietary fat and cholesterol. Nutr. Met. Cardiovasc. Dis. 1:1991;10-12.
30. Glatz J.F.C., Demacker P.N.M., Turner P.R., Katan M.B. Response of serum cholesterol to dietary cholesterol in relation to apolipoprotein E phenotype. NMCD. 1:1991;13-17.
31. Manttari M., Koskinen P., Ehnholm C., Huttunen J.K., Manninen V. Apolipoprotein E polymorphism influences the serum cholesterol response to dietary intervention. Metabolism. 40:1991;217-221.
32. Gaddi A., Ciarrocci A., Matteucci A., Rimondi S., Ravaglia G., Descovish G.C., Sirtori C.R. Dietary treatment for familial hypercholesterolemia - differential effects of dietary soy protein according to the apolipoprotein E phenotypes. Am. J. Clin. Nutr. 53:1991;1191-1196.
33. Xu C.F., Angelico F., Del Ben M., Pannozzo F., Mazzarella B., Miller N.E., Humphries S.E., Talmud P.J. Polymorphisms at the apolipoprotein loci and response of plasma lipids to dietary change in Italian children. NMCD. 2:1992;26-32.
34. Friedlander Y., Kaufman N.A., Cedar H., Kark J.D. XbaI polymorphism of the apolipoprotein B gene and plasma lipid and lipoprotein response to dietary fat and cholesterol: a clinical trial. Clin. Genet. 43:1993;223-231.
35. Friedlander Y., Berry E.M., Eisenberg S., Stein Y., Leitersdorf E. Plasma lipids and lipoproteins response to a dietary challenge: analysis of four candidate genes. Clin. Genet. 47:1995;1-12.
36. Jemaa R., Tuzet S., Betoulle D., Apfelbaum M., Fumeron F. Hind III polymorphism of the lipoprotein lipase gene and plasma lipid response to low calorie diet. Int. J. Obes. 21:1997;280-283.
37. Guggenheim J.K., Kaufmann N.A., Reshef A. Food composition tables, College of Nutrition and Home Economics. 6th edition :1980;Ministry of Education and Culture, Goverment of Israel, Jerusalem.
38. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma-without use of preparative ultracentrifuge. Clin. Chem. 18:1972;449-502.
39. Friedlander Y., Kark J.D., Eisenberg S., Stein Y. Calculation of LDL-cholesterol from total cholesterol, triglyceride and HDL-cholesterol: A comparison of methods in the Jerusalem Lipid Research Clinic prevalence study. Isr. J. Med. Sci. 18:1982;1242-1252.
40. Boerwinkle E., Le S.S., Butler R., Schumaker V.N., Chan L. Rapid typing of apolipoprotein B polymorphisms by DNA amplification. Atherosclerosis. 81:1990;225-232.
41. Ludwig E.H., Blackhart B.D., Pierotti V.R., Caiati L., Fortier C., Knott T., Scott J., Mahley R.W., Levy-Wilson B., McCarthy B.J. DNA sequence of the human apolipoprotein B gene. DNA. 6:1987;363-372.
42. Hixson J.E., Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31:1990;545-548.
43. Deeb SS, Peng RL. Structure of the human lipoprotein lipase gene [published erratum appears in Biochemistry 1989 Aug 8;28(16):6786]. Biochemistry 1989; 28:4131-4135.
44. Deeb SS, Peng RL. Structure of the human lipoprotein lipase gene [published erratum appears in Biochemistry 1989 Aug 8;28(16):6786]. Biochemistry 1989; 28:4131-4135.
45. Reymer P.W.A., Gagne E., Groenemeyer B.E., Zhang H., Forysyth I., Jansen H., Seidell J.C., Kromhout D., Lie K.E., Kastelein J., Hayden M.R. A lipoprotein lipase mutation (Asn291Ser) is associated with reducd HDL cholesterol levels in premature athrosclerosis. Nat. Genet. 10:1995;28-34.
46. Funke H., Wiebusch H., Fuer L., Muntoni S., Schulte H., Assmann G. Identification of mutations in the cholesterol ester transfer protein in Europeans with elavated high density lipoprotein cholesterol. Circulation. 90:1994;I241.
47. Fleiss J.L. The Design and Analysis of Clinical Experiments. 1985;Wiley, New York.
48. Hallman D.M., Boerwinke E., Saha N., Sandholzer C., Menzel H.J., Csazar A., Utermann G. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am. J. Hum. Genet. 49:1991;338-389.
49. Myant N.B., Gallagher J., Babir M., et al. Restriction fragment length polymorphism in the apoB gene in relation to coronary artery disease. Atherosclerosis. 77:1989;193-201.
50. Paulweber B., Friedl W., Krempler F., et al. Association of DNA polymorphism at the apolipoprotein B gene locus with coronary heart disease and serum very low density lipoprotein levels. Atherosclerosis. 10:1990;17-24.
51. Genest J.J., Ordovas J.M., McNamara J.R., et al. DNA polymorphisms of the apolipoprotein B gene in patients with premature coronary heart disease. Atherosclerosis. 82:1990;7-17.
52. Ferns GA, Robinson D, Galton DJ. DNA haplotypes of the human apoprotein B gene in coronary atherosclerosis, Hum Genet 1988;81:8176-8180.
53. Berg K., Powell L.M., Wallis S.C., Pease R., Knoott T.J., Scott J. Genetic linkage between antigenic group (Ag) variation and the apolipoprotein B Gene:assignment of the Ag locus. Proc. Natl. Acad. Sci. USA. 83:1986;7367-7370.
54. Berg K. Role of genetic factors in atherosclerotic disease. Am. J. Clin. Nutr. 49:1989;1025-1029.
55. Berg K. Twin studies of coronary heart disease and its risk factors. Acta Genet. Med. Gemellol. (Roma). 36:1987;439-453.
56. Rantala M, Rantala TT, Savolainen M, Friedlander Y, Kesaniemi YA. Apolipoprotein B gene polymorphisms and serum lipids- meta-analysis of the role of genetic variation on diet responsiveness, Am J Hum Nutr, 2000 (in press).
57. Abbey M., Hirata F., Chen G.C., et al. Restriction fragment length polymorphism of the apolipoprotein B gene and response to dietary fat and cholesterol. Can. J. Cardiol. Suppl. G. 11:1995;79-85.
58. Knott T.J., Pease R.J., Powell L.M., Wallis S.C., Rall S.C. Jr., Innerarity T.L., Blackhart B., Taylor W.H., Marcel Y.L., Milne R.W., Johnson D., Fuller M., Lusis A.J., McCarthy B.J., Mahley R.W., Levy-Wilson B., Scott J. Complete protein sequence and identification of structural domains of human apolipoprotein B. Nature. 323:1986;734-738.
59. Gallagher J.J., Myant N.B. Does the EcoRI polymorphism in the apolipoprotein B gene affect the binding of low density lipoprotein to the low density lipoprotein receptor. Artherioscler. Thromb. 12:1992;256-260.
60. Tikkanen M.J. Apolipoprotein E polymorphism and plasma cholesterol response to dietary change. Simopoulos A.P. Genetic Variation and Dietary Response. 1977;15-21 World Rev Nutr Diet, Basel, Karger.
61. Miettinen T.A., Gylling H., Vanhanen H., Ollus A. Cholesterol absorption, elimination, and synthesis related to LDL kinetics during varying fat intake in men with different apoprotein E phenotypes. Atheroscler. Thromb. 12:1992;1044-1052.
62. Nikkila M., Solakivi T., Lehtimaki T., Koivula T., Laippala P., Astrom B. Postprandial plasma lipoprotein changes in relation to apolipoprotein E phenotypes and low density lipoprotein size in men with and without coronary artery disease. Atherosclerosis. 106:1994;149-157.
63. Davignon J.R., Gregg E., Sing C.F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 8:1988;1-21.
64. Ordovas M.J., Lopez-Miranda J., Mata P., Perez-Jimenez F., Lichtenstein A.H., Schaefer E.J. Gene-diet interaction in determining plasma lipid response to dietary intervention. Atherosclerosis. Suppl. 118:1995;S11-S27.
65. Fisher R.M., Mailly F., Peacock R.E., Hamsten A., Seed M., Yudkin J.S., Beisiegel U., Feussner G., Miller G., Humphries S.E., et al. Interaction of the lipoprotein lipase asparagine 291→serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: a study in hyperlipidemic subjects, myocardial infarction survivors, and healthy adults. J. Lipid Res. 36:1995;2104-2112.
66. Karpe F., Steiner G., Olivercrona T., Carlson L.A., Hamsten A. Metabolism of triglyceride-rich lipoproteins during alimentary lipemia. J. Clin. Invest. 91:1993;748-758.
67. Gerdes C., Fisher R.M., Nicaud V., Boer J., Humphries S.E., Talmud P.J., Faergeman O. Lipoprotein lipase variants D9N and N291S are associated with increased plasma triglyceride and lower high-density lipoprotein cholesterol concentrations: studies in the fasting and postprandial states: the European Atherosclerosis Research Studies. Circulation. 96:1997;733-740.
68. Peacock R., Hamsten A., Nilsson-Ehle P., Humphries S.E. Associations between lipoprotein lipase polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden. Atherosclerosis. 97:1992;171-185.
69. Thorn J.A., Needham W.A., Stocks J., Galton D.J. The Ser447-Ter mutation of the lipoprotein lipase gene relates to variability of serum lipid and lipoprotein levels in monozygotic twins. J. Lipid Res. 39:1998;437-441.
70. Jemaa R., Tuzet S., Betoulle D., Apfelbaum M., Fumeron F. Hind III polymorphism of the lipoprotein lipase gene and plasma lipid response to low calorie diet. Int. J. Obes. 21:1997;280-283.
71. Jemaa R., Fumeron F., Poirier O., Lecerf L., Evans A., Arveiler D., Luc G., Cambou J.P., Bard J.M., Fruchart J.C., Apfelbaum M., Cambien F., Tiret L. Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. J. Lipid Res. 36:1995;2141-2146.
72. Kozaki K., Gotoda T., Kawamura M., Shimano H., Yazaki Y., Ouchi Y., Orimo H., Yamada N. Mutational analysis of human lipoprotein lipase by carboxy-terminal truncation. J. Lipid Res. 34:1993;1765-1772.
73. Zhang H., Henderson H., Gagne S.E., Clee S.M., Miao L., Liu G.Q., Hayden M.R. Common sequence variants of lipoprotein lipase: standardized studies of in vitro expression and catalytic function. Biochim. Biophys. Acta. 1302:1996;159-166.